ArticleActa neuropathologica communications2026
Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets.
Anaïs Brunet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.